BC Platforms, Monash University Announce Partnership
News Jun 28, 2016
BC Platforms has announced that it will partner with Monash University to develop and improve methods for storing, retrieving, organising and analysing genomic and clinical data. BC Platforms will provide Monash with all its core suite of products including BC|GENOME for statistical analyses within genomics, BC|PREDICT for variant interpretation and BC|SAFEBOX to safely share sensitive data between scientists at Monash and its key collaborators around the world.
BC Platforms will also support the ASPREE (ASPirin in Reducing Events in the Elderly) international clinical trial being led by the School of Public Health and Preventive Medicine at Monash and the Berman Centre for Outcomes and Clinical Research in the USA. The trial is investigating whether daily low-dose aspirin improves quality of life for older people.
The randomised, double blind, placebo-controlled study for primary prevention of cardiovascular disease, dementia, depression and some cancers is being undertaken in Australia and the USA and has over 19,000 participants. Participant follow-up is conducted longitudinally for an average of five years with extensive phenotypic and clinical data collection. The ASPREE Healthy Ageing Biobank will facilitate genetic and biomarker studies across thousands of biospecimens from the study.
“We are pleased to welcome Monash University as a customer in our global network of leading research units. Monash clearly is among those entities who can drive and impact the whole healthcare industry with their innovative capabilities including the unique ASPREE initiative,” said Nino da Silva, EVP, Sales and Marketing at BC Platforms. “Our primary goal is to deliver a platform to the University that will provide researchers worldwide with timely and easy to access large-scale data sets in order to bring clinical benefits to patients.”
Dr Paul Lacaze, Head of the Public Health Genomics Program in the School of Public Health and Preventive Medicine at Monash, commented: “We are delighted to partner with BC Platforms and believe that with their support we can now tackle a more ambitious range of epidemiological, clinical and genetic research questions. This will require analysing data sets of increasing size and scale as our research program continues to grow in coming years.”
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018